Our Contributors BioTech Health X Latest from BioTech Health X Virios Therapeutics Stock Plunges 70% on Fibromyalgia Clinical Trial Failure Results CEL-SCI Multikine Phase 3 Data Highlighted at ESMO 2022 Mayo Clinic, Hibiscus BioVentures, and Innoforce Announce Mayflower Cell and Gene Therapy Accelerator SyneuRx CEO Dr. Emil Tsai Exclusive Interview with Insights & Projections Krystal Biotech Announces FDA IND Acceptance for KB407 Cystic Fibrosis Clinical Trial ImmunityBio Announces FDA Acceptance of BLA for N-803 Anktiva Bladder Cancer Drug Jak Thomson Studied UC Davis School of Medicine. Enjoy Surfing, Sunning and Helping People. Bylines and analysis in Biotech on major publications. Current Biotech Analyst & Consultant. Latest from Jak Thomson MacroGenics Announces Failure in SOPHIA Study of MARGENZA for Metastatic Breast Cancer Patients Exclusive: Cel-Sci CEO Geert Kersten Talks Multikine, FDA Approval, CVM Future Denali Therapeutics Announces Scientific Journal Publication of Preclinical Proof of Concept for Protein Transport Vehicle (PTV) Indapta Therapeutics Announces Data Demonstrating G-NK Cells Enhance Efficacy in Multiple Myeloma Presenters Announced for 2021 William Blair Biotech Conference BenchSci Expands Advisory Board with New Pharma R&D Leaders
